RCS - Directa Plus PLC - Gipave graphene asphalt trial in Kent

Directa PlusAnnouncement

25/06/2020 07:00

RNS Number : 9790Q
  
Directa Plus PLC
  
25 June 2020
  
 

25 June 2020
 
Directa Plus plc
("Directa Plus" or the "Company")
 
Gipave graphene asphalt trial in Kent
 
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company supplied Gipave, the Company's proprietary asphalt supermodifier, for use in a road trial in Kent, United Kingdom starting this month
 
Directa is working in collaboration with its industrial partner Iterchimica and Kent County Council, to resurface an existing road on East Hill, Dartford.
 
This follows previously announced trials in Rome, Italy, and in Oxfordshire, United Kingdom, which showed that Gipave increases the lifespan and durability of road surfaces, through the addition of a G+ graphene super modifier.
 
Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "Directa's vision is to use graphene technology to enhance existing products, to provide better outcomes for end users. Gipave is an excellent example of the products Directa produces, it allows for stronger, more durable road surfaces, and is fully recyclable. The wide adoption of Gipave road surfaces will reduce the long term financial and environmental costs of road construction for drivers and local governments alike."
-ends-
 
For further information please visit http://www.directa-plus.com/ or contact:
 




Directa Plus plc


+39 02 36714458




Giulio Cesareo, CEO


 




Marco Ferrari, CFO


 




Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)


+44 20 7894 7000




Rick Thompson, Philip Davies, Will Goode(Corporate Finance)


 




N+1 Singer (Joint Broker)


+44 20 7496 3069




Mark Taylor


 




Tavistock (Financial PR and IR)


+44 20 7920 3150




Simon Hudson, Edward Lee


 




 
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
NRASEUFLLESSELM